Insider Ownership Activity for PERCEPTIVE ADVISORS LLC

SEC Forms 3/4/5 positions, issuer links, and transaction evidence for this reporting owner.

Linked issuers

30

Largest position

Crinetics Pharmaceuticals, Inc.

Disclosed value

$1.02B

Transaction activity

Available

Reporting-owner positions (Forms 3/4/5): Forms 3/4/5 connect reporting owners to issuers, positions, and transactions disclosed to the SEC. They are filing-backed ownership signals, not a complete capitalization table.
Estimated position value
3/4/5
$1.02B
Estimated from parsed Forms 3/4/5 when filings include enough share and price data.
Source: Forms 3/4/5Confidence: Estimate depends on reported shares and prices
Linked issuers
3/4/5
30
Distinct issuers connected to this reporting owner in parsed SEC filings.
Scope: Reporting-owner relationships, not all shareholders
Largest linked position
3/4/5
Crinetics Pharmaceuticals, Inc. (CRNX)
$200.34M from parsed reporting-owner filings.
Source: Linked issuer filing trail
Latest parsed filing
SEC
18 Jun 2026
Most recent reporting-owner filing date in the parsed SEC record.
Freshness: Most recent parsed reporting-owner filing
Crinetics Pharmaceuticals, Inc. (CRNX)
Filing-backed value: $200.34M · Role: 10%+ Owner
VBI Vaccines Inc/BC
Filing-backed value: $137.17M · Role: 10%+ Owner
SOLENO THERAPEUTICS INC (SLNO)
Filing-backed value: $112.18M · Role: 10%+ Owner
Immatics N.V. (IMTX)
Filing-backed value: $102.8M · Role: Director
MeiraGTx Holdings plc (MGTX)
Filing-backed value: $93.42M · Role: Director, 10%+ Owner
ALBIREO PHARMA, INC.
Filing-backed value: $84.96M · Role: 10%+ Owner
+24 more
Additional issuer positions are listed below.
How to read Forms 3/4/5 positions
Reported values are filing-backed estimates from parsed SEC Forms 3/4/5 when the filing includes enough share and price data.
Use this as reporting-owner context, not as a full capitalization table or a public-float ownership breakdown.
Reporting-owner location: New York, NY
Latest reporting-owner signature: /s/ Joseph Edelman - for Perceptive Advisors LLC, By: Joseph Edelman, its managing member
Source: Latest parsed Forms 3/4/5 signature
Source filing history: Open source filing history
Source: SEC Forms 3/4/5Freshness: Reporting-owner filing trail

Follow Filing Activity

Follow PERCEPTIVE ADVISORS LLC and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Reported issuer positions for PERCEPTIVE ADVISORS LLC

CRNX Forms 3/4/5

Crinetics Pharmaceuticals, Inc.

Relationship: 10%+ Owner
Holdings value: $200,336,855
Past year net change
Change %
Report period: 18 Apr 2022

VBIV Forms 3/4/5

VBI Vaccines Inc/BC

Relationship: 10%+ Owner
Holdings value: $137,168,813
Past year net change
Change %
Report period: 04 Apr 2023

SLNO Forms 3/4/5

SOLENO THERAPEUTICS INC

Relationship: 10%+ Owner
Holdings value: $112,175,587
Past year net change
Change %
Report period: 26 Sep 2023

IMTX Forms 3/4/5

Immatics N.V.

Relationship: Director
Holdings value: $102,796,214
Past year net change
Change %
Report period: 16 Jun 2026

MGTX Forms 3/4/5

MeiraGTx Holdings plc

Relationship: Director, 10%+ Owner
Holdings value: $93,416,772
Past year net change
Change %
Report period: 11 Jun 2026

ALBO Forms 3/4/5

ALBIREO PHARMA, INC.

Relationship: 10%+ Owner
Holdings value: $84,959,867
Past year net change
Change %
Report period: 11 Oct 2022

ATXS Forms 3/4/5

Astria Therapeutics, Inc.

Relationship: Director
Holdings value: $67,172,360
Past year net change
Change %
Report period: 01 Feb 2024

ADMA Forms 3/4/5

ADMA BIOLOGICS, INC.

Relationship: 10%+ Owner
Holdings value: $59,945,935
Past year net change
Change %
Report period: 28 Sep 2021

VRCA Forms 3/4/5

Verrica Pharmaceuticals Inc.

Relationship: 10%+ Owner
Holdings value: $51,398,078
Past year net change
Change %
Report period: 27 Dec 2023

ALDX Forms 3/4/5

Aldeyra Therapeutics, Inc.

Relationship: 10%+ Owner
Holdings value: $27,829,793
Past year net change
Change %
Report period: 03 Apr 2025

OBIO Forms 3/4/5

Orchestra BioMed Holdings, Inc.

Relationship: 10%+ Owner
Holdings value: $18,679,378
Past year net change: +$6,049,850
Change %: +48%
Report period: 01 Aug 2025

AGRX Forms 3/4/5

AGILE THERAPEUTICS INC

Relationship: 10%+ Owner
Holdings value: $18,406,312
Past year net change
Change %
Report period: 13 Oct 2021

LONA Forms 3/4/5

Athira Pharma, Inc.

Relationship: Director, 10%+ Owner
Holdings value: $17,718,931
Past year net change
Change %
Report period: 23 Dec 2025

VYNE Forms 3/4/5

VYNE Therapeutics Inc.

Relationship: 10%+ Owner
Holdings value: $11,251,930
Past year net change
Change %
Report period: 16 Aug 2021

CRGX Forms 3/4/5

CARGO Therapeutics, Inc.

Relationship: Former 10% Owner
Holdings value: $4,999,995
Past year net change
Change %
Report period: 14 Nov 2023

ACRV Forms 3/4/5

Acrivon Therapeutics, Inc.

Relationship: 10%+ Owner
Holdings value: $4,159,546
Past year net change
Change %
Report period: 30 Apr 2025

ADGM Forms 3/4/5

Adagio Medical Holdings, Inc.

Relationship: Director, 10%+ Owner
Holdings value: $3,505,231
Past year net change: +$3,505,232
Change %: +100%
Report period: 20 Oct 2025

RAIN Forms 3/4/5

Rain Therapeutics Inc.

Relationship: 10%+ Owner
Holdings value: $3,009,293
Past year net change
Change %
Report period: 07 Oct 2021

ISO Forms 3/4/5

IsoPlexis Corp

Relationship: 10%+ Owner
Holdings value: $2,974,560
Past year net change
Change %
Report period: 12 Oct 2021

CEMI Forms 3/4/5

CHEMBIO DIAGNOSTICS, INC.

Relationship: 10%+ Owner
Holdings value: $1,652,698
Past year net change
Change %
Report period: 04 Apr 2023

QTNT Forms 3/4/5

Quotient Ltd

Relationship: 10%+ Owner
Holdings value: $635,617
Past year net change
Change %
Report period: 31 Oct 2022

LIANY Forms 3/4/5

LianBio

Relationship: Director, 10%+ Owner
Holdings value: $81,310
Past year net change
Change %
Report period: 15 Feb 2024

LYRA Forms 3/4/5

Lyra Therapeutics, Inc.

Relationship: 10%+ Owner
Holdings value: $54,702
Past year net change: -$526,734
Change %: -91%
Report period: 11 Nov 2025

CERE Forms 3/4/5

Cerevel Therapeutics Holdings, Inc.

Relationship: Director
Holdings value: $0
Past year net change
Change %
Report period: 20 Feb 2024

KARD Forms 3/4/5

Kardigan, Inc.

Relationship: Director
Holdings value
Past year net change
Change %
Report period: 17 Jun 2026

LABP Forms 3/4/5

Landos Biopharma, Inc.

Relationship: 10%+ Owner
Holdings value
Past year net change
Change %
Report period: 10 Jan 2023

CYPH Forms 3/4/5

LEAP THERAPEUTICS, INC.

Relationship: 10%+ Owner
Holdings value
Past year net change
Change %
Report period: 24 Sep 2021

NAUT Forms 3/4/5

Nautilus Biotechnology, Inc.

Relationship: Director, 10%+ Owner
Holdings value
Past year net change
Change %
Report period: 14 Jun 2024

SLDB Forms 3/4/5

Solid Biosciences Inc.

Relationship: Director, 10%+ Owner
Holdings value
Past year net change
Change %
Report period: 10 Jun 2026

VAPO Forms 3/4/5

VAPOTHERM INC

Relationship: 10%+ Owner
Holdings value
Past year net change
Change %
Report period: 17 Jun 2024

Recent insider transactions for PERCEPTIVE ADVISORS LLC

Sym	Company	Class	Transaction	%	SEC-reported value	SEC-reported price	Shares	Shares after	Date	Ownership

^* marks a reported price that did not pass the local price check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .